SYNBIOTIC SE
NuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
363.55%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€2.68
-€0.01 (-0.19%)
Realtime-Data from 23.09.2025 15:44:06
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€14.98M
Enterprise Value
€18.05M
26 week avg vol.
5599537
Primar Exchange
Xetra
IPO
2019
Sector
health-care-pharma
Headquarters
Munich, DE
Employees
75
Incorporated
2015
CEO
Daniel Kruse
Website
Institutional Investors
47.00%
Management
7.60%
Free Float
45.40%
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86M | 15.92M | 22.99M |
| EBITDA | -7.19M | -1.01M | 1.84M |
| EBIT | -11.75M | -2.13M | 756.62K |
| EPS | -2.12 | -0.30 | 0.06 |
| FCF | -2.94M | -4.33M | 1.35M |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 4.68x | 1.12x | 0.71x |
| EV / EBITDA | (2.51x) | (17.53x) | 8.95x |
| EV / EBIT | (1.54x) | (8.35x) | 21.71x |
| Price / Earnings | (1.26x) | (8.78x) | 44.28x |
| EV / FCF | (6.13x) | (4.11x) | 12.14x |
Downloads
Latest Research
Initiation